- Home
- GDRX vs NEO Comparison
GDRX vs NEO Comparison
Compare GDRX & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDRX | NEO |
|---|---|---|
| Founded | 2011 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Precision Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2020 | 2008 |
Fundamental Metrics
Financial Performance| Metric | GDRX | NEO |
|---|---|---|
| Price | $2.96 | $13.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 8 |
| Target Price | $3.66 | ★ $13.38 |
| AVG Volume (30 Days) | 987.0K | ★ 3.0M |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 125.00 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $796,853,000.00 | N/A |
| Revenue This Year | N/A | $10.63 |
| Revenue Next Year | $5.38 | $9.73 |
| P/E Ratio | $28.94 | ★ N/A |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $1.77 | $4.72 |
| 52 Week High | $5.61 | $15.57 |
Technical Indicators
Market Signals| Indicator | GDRX | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 50.66 | 55.78 |
| Support Level | $2.64 | $13.80 |
| Resistance Level | $2.95 | $15.31 |
| Average True Range (ATR) | 0.11 | 0.68 |
| MACD | -0.03 | -0.21 |
| Stochastic Oscillator | 26.92 | 24.08 |
Price Performance
Historical ComparisonAbout GDRX GoodRx Holdings Inc.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.